Enanta Pharmaceuticals (ENTA) EBT Margin (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,225.00 |
| Dec 31, 2025 | 5,942.00 |
| Sep 30, 2025 | -2,391.00 |
| Jun 30, 2025 | 6,093.00 |
| Mar 31, 2025 | -2,656.00 |
| Dec 31, 2024 | 6,592.00 |
| Sep 30, 2024 | -7,153.00 |
| Jun 30, 2024 | 5,655.00 |
| Mar 31, 2024 | 419.00 |
| Dec 31, 2023 | -3,311.00 |
| Sep 30, 2023 | 2,853.00 |
| Jun 30, 2023 | 2,694.00 |
| Mar 31, 2023 | -8,833.00 |
| Dec 31, 2022 | 657.00 |
| Sep 30, 2022 | 3,542.00 |
| Jun 30, 2022 | 1,445.00 |
| Mar 31, 2022 | -7,043.00 |
| Dec 31, 2021 | 3,260.00 |
| Sep 30, 2021 | 1,284.00 |
| Jun 30, 2021 | -968.00 |
| Mar 31, 2021 | -10,821.00 |
| Dec 31, 2020 | 4,224.00 |
| Sep 30, 2020 | 3,591.00 |
| Jun 30, 2020 | -7,883.00 |
| Mar 31, 2020 | -6,437.00 |
| Dec 31, 2019 | 1,147.00 |
| Sep 30, 2019 | 306.00 |
| Jun 30, 2019 | 1,153.00 |
| Mar 31, 2019 | -4,018.00 |
| Dec 31, 2018 | -1,083.00 |
| Sep 30, 2018 | 1,152.00 |
| Jun 30, 2018 | 118.00 |
| Mar 31, 2018 | 45.00 |
| Dec 31, 2017 | -3,213.00 |
| Sep 30, 2017 | 23,919.00 |
| Jun 30, 2017 | -6,683.00 |
| Mar 31, 2017 | -3,737.00 |
| Dec 31, 2016 | -4,214.00 |
| Sep 30, 2016 | -1,587.00 |
| Jun 30, 2016 | -388.00 |
| Mar 31, 2016 | -7,487.00 |
| Dec 31, 2015 | 4,514.00 |
| Sep 30, 2015 | 1,186.00 |
| Jun 30, 2015 | -6,786.00 |
| Mar 31, 2015 | -597.00 |
| Dec 31, 2014 | 28,401.00 |
| Sep 30, 2014 | -27,609.00 |
| Jun 30, 2014 | 32,395.00 |
| Mar 31, 2014 | 36,046.00 |
| Dec 31, 2013 | -27,199.00 |
| Sep 30, 2013 | -7,842.00 |
| Jun 30, 2013 | 8,041.00 |
| Mar 31, 2013 | -41,010.00 |
| Dec 31, 2012 | 29,699.00 |
| Sep 30, 2012 | -8,135.00 |
| Jun 30, 2012 | -22,472.00 |